Zhang, Lun <br/><br/>
MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma.  [electronic resource] 

 -  Cancer letters  06 2020 
 - 29-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2020.03.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Autophagy--drug effects<br/>Bortezomib--administration & dosage<br/>Cell Line, Tumor<br/>Chloroquine--administration & dosage<br/>Drug Resistance, Neoplasm--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Mice, SCID<br/>MicroRNAs--genetics<br/>Multiple Myeloma--drug therapy<br/>Myristoylated Alanine-Rich C Kinase Substrate--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays